Event owner lens
Use this record to benchmark whether a comparable event makes the work after the room visible. The score is 45/100, so the next move is to benchmark the weakest pillars before repeating the format.
action-oriented convening agenda analysis
Mps world summit virtual pre-conference 1
This action-oriented convening in Academic / Research / Science shows 80 visible agenda rows from mpsworldsummit.org and scores 45/100: a moderate design signal with incomplete evidence. The clearest public signals sit in Future-of-Work Fit and Learning Transfer; the main limits are Follow Through and Participation Architecture. Visible mechanisms include Participant work, Commitments, Feedback, and Network design. Follow-through or tracking is at least visible enough to inspect, though causal proof still depends... A practical reading: For a reader, this is a useful but still incomplete public example: it reads as an action-oriented convening, with the strongest visible signal in future-of-work fit and learning transfer and the biggest open question around follow through and participation architecture. The practical test is whether the published agenda connects the room to post-event continuation and evidence. This page is an original public-evidence analysis, not a copy of the source agenda or an endorsement of the event. The score places the visible agenda in the moderate design signal band. The strongest visible pillars are Future-of-Work Fit, Learning Transfer, and Personalization; the thinnest visible pillars are Follow Through, Participation Architecture, and Problem Specificity. Visible mechanisms include Participant work, Commitments, Feedback, Network design, and Learning transfer. The extracted agenda preview includes 155 visible rows. The most common formats are Presentation, Unknown, and Workshop; the most common inferred purposes are Knowledge Transfer, Unknown, and Participant Work.
Eight-pillar fingerprint
Hover any pillar to see what it measures and, where it scored low, what the agenda is missing.
Participation Architecture?30
Participation Architecture - 30/100. Participant work, contribution, interaction, and alternatives to passive broadcast.Missing: Turn passive airtime into participant work: practice, sensemaking, decisions, critique, or artifact creation.
Follow Through?16
Follow Through - 16/100. Owners, dates, commitments, progress checks, and accountability after the room.Missing: Add named owners, dates, implementation checkpoints, and a visible post-event continuation path.
Problem Specificity?43
Problem Specificity - 43/100. A clear costly problem, objective, decision, or performance target.Missing: Name the costly problem, decision, or performance target the gathering is meant to move.
Personalization?53
Personalization - 53/100. Role, path, goal, preparation, or connection tailoring for participants.
Network Design?45
Network Design - 45/100. Structured weak ties, bridge-building, mixers, and relationship persistence.
Learning Transfer?59
Learning Transfer - 59/100. Applied practice, feedback, workplace use, refreshers, and 30-90 day transfer.
Evidence Maturity?45
Evidence Maturity - 45/100. Baseline, comparison, follow-up, isolation, and attribution confidence.
Future-of-Work Fit?70
Future-of-Work Fit - 70/100. Value against time, hybrid reality, accessibility, AI, and meeting load.
Fix the gaps
Field-tested exercises matched to this agenda's weakest pillars, from the exercise library.
Follow Through (16/100)
Exercises that strengthen it: Mental Toughness Workshop • WorkshopBank · 15% Solutions • WorkshopBank · Network Patches
Participation Architecture (30/100)
Exercises that strengthen it: Make A World · Awestruck 3 Minutes · Spectrum Mapping
Problem Specificity (43/100)
Exercises that strengthen it: 0 - “Two Person Scene” Theory · Challenge Axis - Knowmium: The Un-Training Consultancy · Fist to Five • WorkshopBank
Agenda Preview
The actual agenda we captured. Every block is classified by format and purpose. Open any block to see how we read it; the colored edge shows whether it is participant work, broadcast, logistics, or a showcase.
Room vs wrapper
9 percent of the 155 classified blocks put participants to work; the rest broadcast, show, or handle logistics. That mix is what drives the participation score.
Participant workBroadcastShowcaseLogistics
all eventRegistrationRegistrationLogistics+
Format · LogisticsRegistrationCheck-in and logistics, not agenda content.
Evidence basisOutcome inferred from formatInferred from format
all eventEducation WorkshopsWorkshopParticipant work+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisParticipant work is implied by the formatInferred from format
all eventPoster InstructionsPoster sessionShowcase+
Format · ShowcasePoster sessionPresenters display work; attendees browse and ask questions. Some interaction, not structured work.
Evidence basisOutcome inferred from formatInferred from format
7 pm - 11 pmSocial event: Creole Queen Dinner Jazz Cruise: Listen to a live jazz band as you dine on a Creole buffet.MealPacing+
Format · LogisticsMealA pacing block. Can carry unstructured networking, not scored as participant work.
Evidence basisOutcome inferred from formatInferred from format
9 am - 11:45 amEducational workshop/Hands-on Training (Salon A)WorkshopParticipant work+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisParticipant work is implied by the formatInferred from format
all eventEducational workshop/Hands-on TrainingWorkshopParticipant work+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisParticipant work is implied by the formatInferred from format
11:45 am - 12:45 pmRound Table (Ballroom AB)RoundtableDiscussion+
Format · Participant workRoundtableSmall-group discussion where attendees contribute directly rather than only listening.
Evidence basisParticipant work is implied by the formatInferred from format
12:50 pm - 2:10 pmpmS1, S2, and S3 Parallel SessionsPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
1:10137. Predictive Nephrotoxicity Testing of Ochratoxin A and Linkage to CKDuPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
10 pm - 1:3079. Standalone Microphysiological System with Precise Oxygen Control for Intestinal-Microbial InteractionsPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
1:5034. Characterizing the reproducibility of a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation - joint study by an MPS developer and a regulatorPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
2:10136. Peristalsis-like deformations increase tumor cell intravasation through GABAergic signaling in a colorectal cancer-on-chip modelPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
1:10194. Peripheral Nervous System Platform towards Disease Modeling and NeurotoxicityPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
10 pm - 1:30232. Human on a chip systems applied to neurodegenative rare diseasesPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
1:5062. Multifluorescent human brain organoid model for high throughput chemical toxicity and drug efficacy screening.PresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
2:10199. Human stem cell-based retina on chip - a screening platform for retinal drug developmentPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
1:10102. A microfluidic thyroid-liver platform to enable cross-species comparison of mechanisms of thyroid toxicity in rats and humansPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
10 pm - 1:30130. Patient-specific human immunocompetent adipose tissue-on-chip models for obesity- and endocrinology researchPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
1:5082. A New Multi-Organ Microfluidic Device to Recapitulate Endocrine Signalling in Vitro: The LATTICE Platform.PresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
2:10189. A microphysiological system coupling of metabolic associated fatty liver disease (MAFLD) to endocrine pancreatic islets: Towards the association and causal link between MAFLD and Type 2 diabetes (T2D)PresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
2:15 pm - 3:35 pmS1, S2, and S3 Parallel SessionsPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
2:3588. Complex in vitro models Representing the Pulmonary SystemPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
2:5544. Development of the Human-Relevant Aerosol Test Platform HUMIMIC - InHALES for Evaluating Respiratory Toxicity and Systemic Effects of Inhaled AerosolsPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
3:15100. An Advanced Drug Screening Platform for Respiratory VirusesPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
3:35Title TBAPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
2:3512. Microphysiological Systems for Immune Cell Trafficking and CapturePresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
2:55180. Modeling Inflammatory Immune Cell Recruitment and Response on Human Colon Intestine-ChipPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
3:15205. Engineered immunocompetent intestinal models: applications in cancer immunotherapy and beyondPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
3:35112. A microfluidic bone marrow chip for the safety profiling of complex large molecules in preclinical drug developmentWorkshopParticipant work+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisParticipant work is implied by the formatInferred from format
2:3543. Multi-organ experiments scaled upPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
2:55192. Multi-organ Microphysiological Systems as Tools to Understand Interorgan Crosstalk in Health and DiseasePresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
3:15144. InterOrgan multi-tissue chip system for linking matured tissue niches by vascular flowPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
3:3511. Establishment of a human multi-organ-chip platform to replace animal transplant models for preclinical evaluation of Treg cell therapiesWorkshopParticipant work+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisParticipant work is implied by the formatInferred from format
4:20268. Human blood-brain barrier model empowered by an engineered basement membranePresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
4:40250. Development of an in vitro 3D neuro-vascular model for Alzheimer’s diseasePresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
4:2015. Cardiovascular MPS models for disease and drug discoveryPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
4:40110. Microgravity-Induced Mitochondrial Dysfunction in Human iPSC-Based 3D Cardiac Microphysiological SystemPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
4:2089. How to best guide the characterization of a thyroid-liver chip: The relevance of combining pathological and metabolic readoutsPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
4:40104. Complex In Vitro Models in Preclinical Toxicologic Pathology - Histotechniques and ExamplesWorkshopParticipant work+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisParticipant work is implied by the formatInferred from format
5:10 pm - 7:10 pmOpening Ceremony/Keynote Lecture - Ballroom ABKeynoteExpert framing+
Format · BroadcastKeynoteA featured talk from the stage. Builds awareness and energy, produces no participant output on its own.
Evidence basisNo participant output visible from this rowRead from source, no work signal
all eventKeynote: Donald E. Ingber, MD, PhDKeynoteExpert framing+
Format · BroadcastKeynoteA featured talk from the stage. Builds awareness and energy, produces no participant output on its own.
Evidence basisNo participant output visible from this rowRead from source, no work signal
all eventRecapitulating human biology, disease states, and therapeutic responses in vitroPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
7:15 pm - 9 pmWelcome ReceptionReceptionOrientation+
Format · LogisticsReceptionA social or hospitality block. Pacing and informal connection, not participant work.
Evidence basisOutcome inferred from formatInferred from format
all eventWelcome Reception at Mark Twain Courtyard - Join us for a taste of New Orleans!ReceptionOrientation+
Format · LogisticsReceptionA social or hospitality block. Pacing and informal connection, not participant work.
Evidence basisOutcome inferred from formatInferred from format
9 am - 9:55 amKeynote (Ballroom AB)KeynoteExpert framing+
Format · BroadcastKeynoteA featured talk from the stage. Builds awareness and energy, produces no participant output on its own.
Evidence basisNo participant output visible from this rowRead from source, no work signal
all eventKeynote: Michael Shuler, PhDKeynoteExpert framing+
Format · BroadcastKeynoteA featured talk from the stage. Builds awareness and energy, produces no participant output on its own.
Evidence basisNo participant output visible from this rowRead from source, no work signal
all eventBody-on-a Chip: The Potential to Transform Drug DevelopmentPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
10:05 am - 12:05 pmS4 and S5 parallel sessionsPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
10:30210. Chemotherapy-Induced Peripheral Neuropathy Using a Nerve-on-a-Chip Microphysiological SystemPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
10:5517. Engineering spatially organized organs-on-chipsPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
11:15259. Biophysical and Biochemical Determinants of Angiogenesis into Synthetic PEG Hydrogels from Perfusable MicrovasculaturePresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
11:35150. Classical Complement Pathway Inhibition in a ‘Human-on-a-Chip’ Model of Autoimmune Demyelinating NeuropathiesPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
11:55182. Electrical pulse stimulation and compounds with anti-atrophic potential influence contractile response of patient-derived skeletal muscle cells in a microphysiological systemPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
10:30267. A novel immunocompetent MPS platform for modeling the cross-talk between 3D tumor tissues and circulating immune cellsPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
10:55226. Organ-on-Chip models recapitulating complex human immunocompetent tissuesPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
11:20279. Tonsil organoids to investigate human adaptive immunityPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
11:40107. Development of a lymphoid organ-on-chip to evaluate CD4+ T cell/B cell interactionsPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
12:15 pm - 1:15 pmDebate (Ballroom AB)PanelDiscussion+
Format · BroadcastPanelExperts discuss while the audience watches. Surfaces perspective but rarely creates participant work.
Evidence basisNo participant output visible from this rowRead from source, no work signal
1:25 pm - 2:55 pmJRC Lunch session: The importance of standards for advancing the MPS field (Ballroom AB)MealPacing+
Format · LogisticsMealA pacing block. Can carry unstructured networking, not scored as participant work.
Evidence basisOutcome inferred from formatInferred from format
1:45281. Standards supporting innovation: the case of Organ-on-ChipPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
2:0522. Open Platform Technology for Organs-on-ChipsPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
2:25287. Standards for integrating heterogenous data and metadata from organ-on-chip technologiesPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
2:45278. Guidelines for microfluidics: how to simplify your OoC Life ?PresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
3 pm - 5 pmS6 and S7 Parallel SessionsPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
3:25213. Systems engineering of microphysiometryPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
3:5074. Identification of variation factors for the development of assays using MPSPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
4:1075. Circadian physiology in microphysiological systemsPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
10 pm - 4:30174. Development of a Functional Human iPSC-Cortical Neuron-MEA Model for Long Term Potentiation Analysis and Alzheimer’s Drug TestingPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
4:50253. IQ MPS Affiliates: Accelerating the development and adoption of MPS models in industryPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
3:2597. A PBPK-compliant human intestine-liver-brain-kidney Chip for QIVIVE in drug developmentPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
3:50118. A continuous, automated perfusion culture and analysis system (CAPCAS) to enable massive parallelization of organs-on-chips, chemostats, and other miniature bioreactorsPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
4:10134. Modeling doxorubicin’s pharmacokinetics and pharmacodynamics in a human InterOrgan chipPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
10 pm - 4:30258. Biodistribution and PK modeling of a multi-organ human-on-a-chip system consisting of a GI tract, blood brain barrier and neuronsPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
4:50129. Using in vitro cell models, kidney MPS, and PBPK modeling to predict human renal clearance: health, disease, and drug interactionPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
5 pm - 7 pmPoster Sessions (Salon CD)Poster sessionShowcase+
Format · ShowcasePoster sessionPresenters display work; attendees browse and ask questions. Some interaction, not structured work.
Evidence basisOutcome inferred from formatInferred from format
all eventRegistrationRegistrationLogistics+
Format · LogisticsRegistrationCheck-in and logistics, not agenda content.
Evidence basisMediumRead from source
all eventPlan Your VisitUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all eventAbstract SubmissionUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all eventEducation WorkshopsWorkshopCo Creation+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisMediumRead from source
all eventPoster InstructionsPoster SessionShowcase+
Format · ShowcasePoster SessionPresenters display work; attendees browse and ask questions. Some interaction, not structured work.
Evidence basisMediumRead from source
all eventPROGRAM AT GLANCEUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all eventFULL PROGRAMUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
9 am - 7 pmTravel and arrival dayUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
7 pm - 11 pmSocial event: Creole Queen Dinner Jazz Cruise: Listen to a live jazz band as you dine on a Creole buffet.MealWellbeing+
Format · LogisticsMealA pacing block. Can carry unstructured networking, not scored as participant work.
Evidence basisMediumRead from source
9 am - 11:45 amEducational workshop/Hands-on Training (Salon A)WorkshopCo Creation+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisMediumRead from source
all eventEducational workshop/Hands-on TrainingWorkshopCo Creation+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisMediumRead from source
11:45 am - 12:45 pmRound Table (Ballroom AB)RoundtableDeliberation+
Format · Participant workRoundtableSmall-group discussion where attendees contribute directly rather than only listening.
Evidence basisMediumRead from source
12:50 pm - 2:10 pmpmS1, S2, and S3 Parallel SessionsPresentationKnowledge Transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisMediumRead from source
1:10 137. Predictive Nephrotoxicity Testing of Ochratoxin A and Linkage to CKDuUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
10 pm - 1:30 79. Standalone Microphysiological System with Precise Oxygen Control for Intestinal-Microbial InteractionsUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
1:50 34. Characterizing the reproducibility of a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation - joint study by an MPS developer and a regulatorUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
2:10 136. Peristalsis-like deformations increase tumor cell intravasation through GABAergic signaling in a colorectal cancer-on-chip modelUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
1:10 194. Peripheral Nervous System Platform towards Disease Modeling and NeurotoxicityUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
10 pm - 1:30 232. Human on a chip systems applied to neurodegenative rare diseasesUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
1:50 62. Multifluorescent human brain organoid model for high throughput chemical toxicity and drug efficacy screening.UnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
2:10 199. Human stem cell-based retina on chip - a screening platform for retinal drug developmentUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
1:10 102. A microfluidic thyroid-liver platform to enable cross-species comparison of mechanisms of thyroid toxicity in rats and humansUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
10 pm - 1:30 130. Patient-specific human immunocompetent adipose tissue-on-chip models for obesity- and endocrinology researchUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
1:50 82. A New Multi-Organ Microfluidic Device to Recapitulate Endocrine Signalling in Vitro: The LATTICE Platform.UnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
2:10 189. A microphysiological system coupling of metabolic associated fatty liver disease (MAFLD) to endocrine pancreatic islets: Towards the association and causal link between MAFLD and Type 2 diabetes (T2D)UnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
2:15 pm - 3:35 pmS1, S2, and S3 Parallel SessionsPresentationKnowledge Transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisMediumRead from source
2:35 88. Complex in vitro models Representing the Pulmonary SystemUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
2:55 44. Development of the Human-Relevant Aerosol Test Platform HUMIMIC - InHALES for Evaluating Respiratory Toxicity and Systemic Effects of Inhaled AerosolsUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
3:15 100. An Advanced Drug Screening Platform for Respiratory VirusesUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
3:35 Title TBAUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
2:35 12. Microphysiological Systems for Immune Cell Trafficking and CaptureUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
2:55 180. Modeling Inflammatory Immune Cell Recruitment and Response on Human Colon Intestine-ChipUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
3:15 205. Engineered immunocompetent intestinal models: applications in cancer immunotherapy and beyondUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
3:35 112. A microfluidic bone marrow chip for the safety profiling of complex large molecules in preclinical drug developmentWorkshopCo Creation+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisMediumRead from source
2:35 43. Multi-organ experiments scaled upUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
2:55 192. Multi-organ Microphysiological Systems as Tools to Understand Interorgan Crosstalk in Health and DiseasePresentationKnowledge Transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisMediumRead from source
3:15 144. InterOrgan multi-tissue chip system for linking matured tissue niches by vascular flowUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
3:35 11. Establishment of a human multi-organ-chip platform to replace animal transplant models for preclinical evaluation of Treg cell therapiesWorkshopCo Creation+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisMediumRead from source
4:20 268. Human blood-brain barrier model empowered by an engineered basement membraneUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
4:40 250. Development of an in vitro 3D neuro-vascular model for Alzheimer’s diseaseUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
4:20 15. Cardiovascular MPS models for disease and drug discoveryUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
4:40 110. Microgravity-Induced Mitochondrial Dysfunction in Human iPSC-Based 3D Cardiac Microphysiological SystemUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
4:20 89. How to best guide the characterization of a thyroid-liver chip: The relevance of combining pathological and metabolic readoutsUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
4:40 104. Complex In Vitro Models in Preclinical Toxicologic Pathology - Histotechniques and ExamplesWorkshopCo Creation+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisMediumRead from source
5:10 pm - 7:10 pmOpening Ceremony/Keynote Lecture - Ballroom ABKeynoteThought Leadership+
Format · BroadcastKeynoteA featured talk from the stage. Builds awareness and energy, produces no participant output on its own.
Evidence basisMediumRead from source
all eventKeynote: Donald E. Ingber, MD, PhDKeynoteThought Leadership+
Format · BroadcastKeynoteA featured talk from the stage. Builds awareness and energy, produces no participant output on its own.
Evidence basisMediumRead from source
all eventRecapitulating human biology, disease states, and therapeutic responses in vitroUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
7:15 pm - 9 pmWelcome ReceptionOpening RemarksOrientation+
Format · BroadcastOpening RemarksFraming or welcome from the stage. Orients the room, not participatory.
Evidence basisMediumRead from source
all eventWelcome Reception at Mark Twain Courtyard - Join us for a taste of New Orleans!Opening RemarksOrientation+
Format · BroadcastOpening RemarksFraming or welcome from the stage. Orients the room, not participatory.
Evidence basisMediumRead from source
9 am - 9:55 amKeynote (Ballroom AB)KeynoteThought Leadership+
Format · BroadcastKeynoteA featured talk from the stage. Builds awareness and energy, produces no participant output on its own.
Evidence basisMediumRead from source
all eventKeynote: Michael Shuler, PhDKeynoteThought Leadership+
Format · BroadcastKeynoteA featured talk from the stage. Builds awareness and energy, produces no participant output on its own.
Evidence basisMediumRead from source
all eventBody-on-a Chip: The Potential to Transform Drug DevelopmentUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
10:05 am - 12:05 pmS4 and S5 parallel sessionsPresentationKnowledge Transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisMediumRead from source
10:30 210. Chemotherapy-Induced Peripheral Neuropathy Using a Nerve-on-a-Chip Microphysiological SystemUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
10:55 17. Engineering spatially organized organs-on-chipsUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
11:15 259. Biophysical and Biochemical Determinants of Angiogenesis into Synthetic PEG Hydrogels from Perfusable MicrovasculatureUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
11:35 150. Classical Complement Pathway Inhibition in a ‘Human-on-a-Chip’ Model of Autoimmune Demyelinating NeuropathiesUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
11:55 182. Electrical pulse stimulation and compounds with anti-atrophic potential influence contractile response of patient-derived skeletal muscle cells in a microphysiological systemUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
10:30 267. A novel immunocompetent MPS platform for modeling the cross-talk between 3D tumor tissues and circulating immune cellsPresentationKnowledge Transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisMediumRead from source
10:55 226. Organ-on-Chip models recapitulating complex human immunocompetent tissuesUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
11:20 279. Tonsil organoids to investigate human adaptive immunityUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
11:40 107. Development of a lymphoid organ-on-chip to evaluate CD4+ T cell/B cell interactionsUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
12:15 pm - 1:15 pmDebate (Ballroom AB)UnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
1:25 pm - 2:55 pmJRC Lunch session: The importance of standards for advancing the MPS field (Ballroom AB)MealWellbeing+
Format · LogisticsMealA pacing block. Can carry unstructured networking, not scored as participant work.
Evidence basisMediumRead from source
1:45 281. Standards supporting innovation: the case of Organ-on-ChipUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
2:05 22. Open Platform Technology for Organs-on-ChipsUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
2:25 287. Standards for integrating heterogenous data and metadata from organ-on-chip technologiesUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
2:45 278. Guidelines for microfluidics: how to simplify your OoC Life ?UnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
3 pm - 5 pmS6 and S7 Parallel SessionsPresentationKnowledge Transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisMediumRead from source
3:25 213. Systems engineering of microphysiometryUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
3:50 74. Identification of variation factors for the development of assays using MPSUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
4:10 75. Circadian physiology in microphysiological systemsUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
10 pm - 4:30 174. Development of a Functional Human iPSC-Cortical Neuron-MEA Model for Long Term Potentiation Analysis and Alzheimer’s Drug TestingUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
4:50 253. IQ MPS Affiliates: Accelerating the development and adoption of MPS models in industryUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
3:25 97. A PBPK-compliant human intestine-liver-brain-kidney Chip for QIVIVE in drug developmentUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
3:50 118. A continuous, automated perfusion culture and analysis system (CAPCAS) to enable massive parallelization of organs-on-chips, chemostats, and other miniature bioreactorsUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
4:10 134. Modeling doxorubicin’s pharmacokinetics and pharmacodynamics in a human InterOrgan chipUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
10 pm - 4:30 258. Biodistribution and PK modeling of a multi-organ human-on-a-chip system consisting of a GI tract, blood brain barrier and neuronsUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
4:50 129. Using in vitro cell models, kidney MPS, and PBPK modeling to predict human renal clearance: health, disease, and drug interactionUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
5 pm - 7 pmPoster Sessions (Salon CD)Poster SessionShowcase+
Format · ShowcasePoster SessionPresenters display work; attendees browse and ask questions. Some interaction, not structured work.
Evidence basisMediumRead from source
The Full Reading
Why It Ranks This Way +
Calibrated from GES design 45/100 and verified 45/100 with no fourth-loop cap.
Reader Takeaway. For a reader, this is a useful but still incomplete public example: it reads as an action-oriented convening, with the strongest visible signal in future-of-work fit and learning transfer and the biggest open question around follow through and participation architecture. The practical test is whether the published agenda connects the room to post-event continuation and evidence.
Strongest signals: Future-of-Work Fit, Learning Transfer, and Personalization. Weakest signals: Follow Through, Participation Architecture, and Problem Specificity.
How This Agenda Could Improve +
- Add named owners, dates, implementation checkpoints, and a visible post-event continuation path.
- Turn passive airtime into participant work: practice, sensemaking, decisions, critique, or artifact creation.
- Name the costly problem, decision, or performance target the gathering is meant to move.
Fastest next move: Add named owners, dated next steps, and a visible continuation path before treating the event as outcome-ready.
Role-Specific Reading +
Sponsor lens
Look beyond exposure. Strong sponsor value would show qualified interaction, problem work, buyer learning, customer evidence, or follow-up. The practical sponsor move is to look for structured introductions, buyer-seller fit, and relationship persistence.
Designer lens
The agenda is useful as a pattern sample from mpsworldsummit.org. Redesign attention should go first to the lowest-scoring pillars; in practice, turn the thinnest agenda blocks into participant work.
Executive lens
Treat the visible agenda as an operating plan. The executive move is to require owners, dates, and evidence before treating the event as strategic. If owners, proof, and follow-through are not visible, the public record does not yet prove strategic movement.
Aggregator lens
Treat the source URL as evidence, not decoration. The data-product move is to label the source boundary clearly before ranking the record before ranking or syndicating the record.
What GES Means Here +
The Gathering Effectiveness Score is a strict 0-100 public-evidence reading of the agenda across eight pillars. It rewards visible participant work, follow-through, transfer, network design, and proof mechanisms more than polish, speaker fame, attendance, or satisfaction.
Visible mechanisms: Participant work, Commitments, Feedback, Network design, Learning transfer, Personalization.
Evidence boundary: Scores reflect visible agenda/source evidence and should not be read as proof of causal event impact.
Limitations, Score Caps, and Review Flags +
Limitations
- Passive stage formats dominate the visible agenda.
- No baseline measurement is visible.
Score caps
- No fourth-loop score cap applied.
Review flags
- No tracking, validation, feedback, or impact measurement found in the visible source text.
- Original category was unknown; publication category is inferred.
Is this proof the event worked? +
No. This is a strict public-evidence reading of the agenda. Proof would require baseline, comparison, follow-up, attribution, and impact evidence beyond the listing.
What should a reader inspect first? +
Start with the source URL, then compare the eight pillar scores against the agenda rows. The biggest opportunities usually sit in follow-through, evidence maturity, and participant work.
Why publish weak records? +
Weak records are part of the map. They show where public agendas still describe sessions and speakers more often than outcomes, commitments, transfer, or proof.
How should I use the rows? +
Read the agenda rows as the visible design trace: formats, purposes, and evidence labels show what the public source made inspectable, not everything that happened in the room. This is a source-grounded interpretation of the public agenda record, not a copy of the source, and not an endorsement of the event.
Embed the verified badge +
This record is in the hand-verified gold set. Copy the snippet below to embed the verified badge on your own site.
<a href="https://unitedwetransform.com/events/evt_2022_mps_world_summit_virtual_pre_conference_1_2022_program_mpsworldsummit_org"><img src="https://unitedwetransform.com/badge/ges-verified.svg" alt="GES verified by United We Transform" height="40"></a>Where To Go Next
Compare this agenda against other Academic / Research / Science events scored on the same eight pillars.